title: Bullous pemphigoid occurring during efalizumab treatment for psoriasis: a paradoxical auto-immune reaction?
authors.forename: Karine
authors.initials: K
authors.lastname: Monnier-Murina
authors.forename: Aurélie
authors.initials: A
authors.lastname: Du Thanh
authors.forename: Séverine
authors.initials: S
authors.lastname: Merlet-Albran
authors.forename: Bernard
authors.initials: B
authors.lastname: Guillot
authors.forename: Olivier
authors.initials: O
authors.lastname: Dereure
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D015551:Autoimmunity / Q000187:drug effects; D018845:CD11 Antigens; D006801:Humans; D008297:Male; D010391:Pemphigoid, Bullous / Q000139:chemically induced* / Q000276:immunology; D011565:Psoriasis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018845:CD11 Antigens; C472181:efalizumab